The Department of Transportation is revising a requirement that it calls an “inadvertent factual impossibility” from its drug testing procedures. A provision from DOT’s 2023 oral fluid drug testing ...
NEW YORK--(BUSINESS WIRE)-- Schrödinger, Inc. (Nasdaq: SDGR) strongly supports the U.S. Food and Drug Administration’s (FDA) plan to reduce, refine or potentially replace current animal testing ...